Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record shows a revision update to v3.6.6. This indicates a minor maintenance/formatting update to the page rather than a change to study data, eligibility criteria, or results.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing v3.6.4. This reflects a minor internal template update with no change to study information or user-facing content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows a new revision tag (v3.6.4) replacing the previous v3.6.3. This indicates a minor maintenance update to the page rather than changes to the study details.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a version update to the page template. No substantive study content appears to be changed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling an internal update to the page framework. The visible study details remain unchanged.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page adds a recruitment status note ('No longer looking for participants') and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), improving user guidance and signaling current recruitment status. It also updates the 'Intervention / Treatment' heading to 'Intervention/Treatment' and changes the revision label from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.